A new analysis has found no evidence that the use of paracetamol during pregnancy increases the risk of autism, attention deficit hyperactivity disorder (ADHD) or intellectual disabilities in children, offering reassurance to expectant mothers.

The findings, published in The Lancet Obstetrics, Gynaecology and Women’s Health, confirm results from earlier studies that employed rigorous scientific methodologies to examine potential links between prenatal paracetamol exposure and neurodevelopmental disorders.

Paracetamol, an over-the-counter medication widely used to treat fever, body aches and mild pain, has been the subject of debate in recent years following reports suggesting possible associations with developmental conditions.

Researchers said the latest analysis reviewed high-quality studies and found no causal relationship between maternal paracetamol intake and increased neurodevelopmental risks in offspring.

The authors noted that while medicines during pregnancy should always be used judiciously and under medical guidance, the findings provide important clarity and reassurance regarding the safety of paracetamol when taken as recommended.

The study underscores the need for evidence-based guidance for pregnant women and highlights the importance of relying on well-designed research when assessing potential health risks.